A malignant lymphoma with histological features and immunophenotypic profile intermediate between EBV-positive diffuse large B-cell lymphoma and EBV-positive classical Hodgkin lymphoma in a 67-year-old female: A " gray zone" lymphoma associated with Epstein-Barr virus in the elderly

Pathology Research and Practice

Volumn 208, Issue 6, 2012, Pages 363-367

  Wang, Endi ^a   Papavassiliou, Paulie ^a   Sebastian, Siby ^a  

^a DUKE UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

Classical Hodgkin lymphoma; Diffuse large B cell lymphoma; EBV; Gray zone lymphoma; Immunodeficiency

Indexed keywords

BLEOMYCIN; CD15 ANTIGEN; CD20 ANTIGEN; CD30 ANTIGEN; CD45 ANTIGEN; CYCLOPHOSPHAMIDE; DOXORUBICIN; ETOPOSIDE; FLUORODEOXYGLUCOSE F 18; LACTATE DEHYDROGENASE; PREDNISONE; PROCARBAZINE; TRANSCRIPTION FACTOR PAX5; VINCRISTINE;

AGED; ANEMIA; ARTICLE; BONE MARROW EXAMINATION; CANCER CHEMOTHERAPY; CANCER REGRESSION; CANCER STAGING; CASE REPORT; CLASSICAL HODGKIN LYMPHOMA; COMPUTER ASSISTED TOMOGRAPHY; DOWN REGULATION; EPSTEIN BARR VIRUS; FATIGUE; FEMALE; FEVER; GENE REARRANGEMENT; GENOTYPE; HUMAN; HUMAN TISSUE; IMMUNOGLOBULIN HEAVY CHAIN GENE; IMMUNOHISTOCHEMISTRY; IMMUNOPHENOTYPING; IN SITU HYBRIDIZATION; LACTATE DEHYDROGENASE BLOOD LEVEL; LARGE CELL LYMPHOMA; LEUKOCYTE COUNT; LYMPH NODE BIOPSY; LYMPHADENOPATHY; LYMPHOCYTE COUNT; MALAISE; MEDIASTINUM LYMPH NODE; MESENTERY LYMPH NODE; NEUTROPHIL COUNT; PARAAORTIC LYMPH NODE; PELVIS LYMPH NODE; POSITRON EMISSION TOMOGRAPHY; REED STERNBERG CELL; RNA HYBRIDIZATION; WEIGHT REDUCTION;

AGED; ANTIGENS, CD15; ANTIGENS, CD30; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; BLEOMYCIN; CYCLOPHOSPHAMIDE; DOXORUBICIN; EPSTEIN-BARR VIRUS INFECTIONS; ETOPOSIDE; FEMALE; GENE REARRANGEMENT, B-LYMPHOCYTE, HEAVY CHAIN; HERPESVIRUS 4, HUMAN; HODGKIN DISEASE; HUMANS; IMMUNOPHENOTYPING; LYMPHOMA, LARGE B-CELL, DIFFUSE; PREDNISONE; PROCARBAZINE; REED-STERNBERG CELLS; REMISSION INDUCTION; VINCRISTINE;

EID: 84861667982     PISSN: 03440338     EISSN: 16180631     Source Type: Journal    
DOI: 10.1016/j.prp.2012.04.003     Document Type: Article

References (23)

1. Asano N., Yamamoto K., Tamaru J., Oyama T., Ishida F., Ohshima K., Yoshino T., Nakamura N., Mori S., Yoshie O., Shimoyama Y., Morishima Y., Kinoshita T., Nakamura S. Age-related Epstein-Barr virus (EBV)-associated B-cell lymphoproliferative disorders: comparison with EBV-positive classic Hodgkin lymphoma in elderly patients. Blood 2009, 113:2629-2636.
2. Coiffier B. Rituximab therapy in malignant lymphoma. Oncogene 2007, 26:3603-3613.
3. Connors J.M. State-of-the-art therapeutics: Hodgkin's lymphoma. J. Clin. Oncol. 2005, 23:6400-6408.
4. Dojcinov S.D., Venkataraman G., Raffeld M., Pittaluga S., Jaffe E.S. EBV positive mucocutaneous ulcer - a study of 26 cases associated with various sources of immunosuppression. Am. J. Surg. Pathol. 2010, 34:405-417.
5. Duggan D.B., Petroni G.R., Johnson J.L., Glick J.H., Fisher R.I., Connors J.M., Canellos G.P., Peterson B.A. Randomized comparison of ABVD and MOPP/ABV hybrid for the treatment of advanced Hodgkin's disease: report of an intergroup trial. J. Clin. Oncol. 2003, 21:607-614.
6. Gadhoum S.Z., Sackstein R. CD15 expression in human myeloid cell differentiation is regulated by sialidase activity. Nat. Chem. Biol. 2008, 4:751-757.
7. Jaffe E.S., Stein H., Swerdlow S.H., Campo E., Pileri S.A., Harris N.L. B-cell lymphoma, unclassifiable, with features intermediate between diffuse large B-cell lymphoma and classical Hodgkin lymphoma. WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues 2008, 267-268. IARC Press, Lyon. S.H. Swerdlow, E. Campo, N.L. Harris (Eds.).
8. Loddenkemper C., Anagnostopoulos I., Hummel M., et al. Differential Emu enhancer activity and expression of BOB.1/OBF.1, Oct2, PU.1, and immunoglobulin in reactive B-cell populations. B-cell non-Hodgkin lymphoma, and Hodgkin lymphoma. J. Pathol. 2004, 202:60-69.
9. Marafioti T., Hummel M., Anagnostopoulos I., Foss H.D., Huhn D., Stein H. Classical Hodgkin's disease and follicular lymphoma originating from the same germinal center B cell. J. Clin. Oncol. 1999, 17:3804-3809.
10. Nakamura S., Jaffe E.S., Swerdlow S.H. EBV positive diffuse large B-cell lymphoma of the elderly. WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues 2008, 243-244. IARC Press, Lyon. S.H. Swerdlow, E. Campo, N.L. Harris (Eds.).
11. Oyama T., Ichimura K., Suzuki R., Suzumiya J., Ohshima K., Yatabe Y., Yokoi T., Kojima M., Kamiya Y., Taji H., Kagami Y., Ogura M., Saito H., Morishima Y., Nakamura S. Senile EBV+ B-cell lymphoproliferative disorders: a clinicopathologic study of 22 patients. Am. J. Surg. Pathol. 2003, 27:16-26.
12. Oyama T., Yamamoto K., Asano N., Oshiro A., Suzuki R., Kagami Y., Morishima Y., Takeuchi K., Izumo T., Mori S., Ohshima K., Suzumiya J., Nakamura N., Abe M., Ichimura K., Sato Y., Yoshino T., Naoe T., Shimoyama Y., Kamiya Y., Kinoshita T., Nakamura S. Age-related EBV-associated B-cell lymphoproliferative disorders constitute a distinct clinicopathologic group: a study of 96 patients. Clin. Cancer Res. 2007, 13:5124-5132.
13. Pitman S.D., Huang Q., Zuppan C.W., Rowsell E.H., Cao J.D., Berdeja J.G., Weiss L.M., Wang J. Hodgkin lymphoma-like posttransplant lymphoproliferative disorder (HL-like PTLD) simulates monomorphic B-cell PTLD both clinically and pathologically. Am. J. Surg. Pathol. 2006, 30:470-476.
14. Purtilo D.T., Strobach R.S., Okano M., Davis J.R. Epstein-Barr virus-associated lymphoproliferative disorders. Lab. Invest. 1992, 67:5-23.
15. Ranganathan S., Webber S., Ahuja S., Jaffe R. Hodgkin-like posttransplant lymphoproliferative disorder in children: does it differ from posttransplant Hodgkin lymphoma?. Pediatr. Dev. Pathol. 2004, 7:348-360.
16. Shimoyama Y., Yamamoto K., Asano N., Oyama T., Kinoshita T., Nakamura S. Age-related Epstein-Barr virus-associated B-cell lymphoproliferative disorders: special references to lymphomas surrounding this newly recognized clinicopathologic disease. Cancer Sci. 2008, 99:1085-1091.
17. Stein H., Delsol G., Pileri S.A., Weiss L.M., Poppema S., Jaffe E.S. Classical Hodgkin lymphoma, introduction. WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues 2008, 326-329. IARC Press, Lyon. S.H. Swerdlow, E. Campo, N.L. Harris (Eds.).
18. Swerdlow S.H., Webber S.A., Chadburn A., Ferry J.A. Post-transplant lymphoproliferative disorders. WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues 2008, 343-351. IARC Press, Lyon. S.H. Swerdlow, E. Campo, N.L. Harris (Eds.).
19. Traverse-Glehen A., Pittaluga S., Gaulard P., et al. Mediastinal gray zone lymphoma: the missing link between classic Hodgkin's lymphoma and mediastinal large B-cell lymphoma. Am. J. Surg. Pathol. 2005, 29:1411-1421.
20. Ushmorov A., Leithäuser F., Sakk O., Weinhaüsel A., Popov S.W., Möller P., Wirth T. Epigenetic processes play a major role in B-cell-specific gene silencing in classical Hodgkin lymphoma. Blood 2006, 107:2493-2500.
21. Ushmorov A., Ritz O., Hummel M., Leithäuser F., Möller P., Stein H., Wirth T. Epigenetic silencing of the immunoglobulin heavy-chain gene in classical Hodgkin lymphoma-derived cell lines contributes to the loss of immunoglobulin expression. Blood 2004, 104:3326-3334.
22. van Krieken J.H., Langerak A.W., Macintyre E.A., et al. Improved reliability of lymphoma diagnostics via PCR-based clonality testing: report of the BIOMED-2 Concerted Action BHM4-CT98-3936. Leukemia 2007, 21:201-206.
23. Wang E., Foo W.C., Huang Q. A sinusoidal large cell lymphoma with expression of CD30, CD15, and multiple B-cell antigens: a classical Hodgkin lymphoma with sinusoidal infiltrating pattern or a sinusoidal CD30 positive large B-cell lymphoma with CD15?. Leuk. Lymphoma 2010, 51:1148-1151.